» Articles » PMID: 20019067

Ultrasound-guided Sacroiliac Joint Injection in Patients with Established Sacroiliitis: Precise IA Injection Verified by MRI Scanning Does Not Predict Clinical Outcome

Overview
Specialty Rheumatology
Date 2009 Dec 19
PMID 20019067
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: IA injections of SIJs with corticosteroids are often performed in patients suffering from low back pain due to active sacroiliitis. However, SIJ injections are technically demanding, and therefore the clinical outcome of ultrasound-guided corticosteroid SIJ injections was analysed in relation to the accuracy of the injection.

Methods: Ultrasound-guided injections were performed with 40 mg triamcinolone and 0.78 mg gadolinium in 20 SIJ of 14 consecutive patients suffering from active sacroiliitis. Immediately following SIJ injection, MRI scanning was initiated to verify the correct placement of the drug. Clinical outcome of the intervention was determined using a numerical pain rating scale (NRS) at Days 1 and 28.

Results: Despite ultrasound guidance, only 8 injections (40%) were exactly positioned into the SIJ space, whereas the other 12 injections (60%) missed the SIJ. However, there were no significant differences observed in the clinical outcome between the IA-injected group and the peri-articular-injected group. There was similar pain relief observed in both groups 24 h and 28 days following the intervention [IA injection group: mean NRS-baseline: 6.8 (range 4-9), NRS-24 h: 4.3 (range 1-7) and NRS-day 28: 3.5 (range 1-5); peri-articular injection group: mean NRS-baseline: 7.0 (range 5-10), NRS-24 h: 4.1 (range 1-10) and NRS-day 28: 4.5 (range 1-8)].

Conclusion: These results demonstrate that IA SIJ injections remain technically challenging despite ultrasound guidance. However, peri-articular deposition of triamcinolone appears sufficient for pain and symptom control in patients suffering from active sacroiliitis.

Citing Articles

Injective Therapies for Managing Sacroiliac Joint Pain in Spondyloarthropathy: A Systematic Review and Meta-Analysis.

Cerasoli T, Filardo G, Favero A, Rinaldi V, Di Maio L, Marcheggiani Muccioli G J Clin Med. 2025; 14(4).

PMID: 40004824 PMC: 11857029. DOI: 10.3390/jcm14041294.


Effectiveness of intra-articular analgesia in reducing postoperative pain after minimally invasive sacroiliac joint fusion: a double-blind randomized controlled trial.

Hermans S, Nellensteijn J, Knoef R, van Santbrink H, Droeghaag R, Most J Sci Rep. 2024; 14(1):22647.

PMID: 39349941 PMC: 11442864. DOI: 10.1038/s41598-024-73638-8.


American Society of Pain and Neuroscience Best Practice (ASPN) Guideline for the Treatment of Sacroiliac Disorders.

Sayed D, Deer T, Tieppo Francio V, Lam C, Sochacki K, Hussain N J Pain Res. 2024; 17:1601-1638.

PMID: 38716038 PMC: 11075694. DOI: 10.2147/JPR.S464393.


Ultrasound-Guided vs. Fluoroscopy-Guided Interventions for Back Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Viderman D, Aubakirova M, Aryngazin A, Yessimova D, Kaldybayev D, Tankacheyev R Diagnostics (Basel). 2023; 13(22).

PMID: 37998610 PMC: 10670286. DOI: 10.3390/diagnostics13223474.


Magnetic resonance imaging/ultrasound fusion-guided sacroiliac joint corticosteroid injection in patients with axial spondyloarthritis.

Aktas I, Sari K, Unlu Ozkan F, Kahraman A, Vural A, Akgun K Turk J Phys Med Rehabil. 2023; 69(1):116-120.

PMID: 37201011 PMC: 10186019. DOI: 10.5606/tftrd.2022.8858.